About this trial

Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.

Eligibility criteria

Qualifiers

Patient with an obstructive sleep apnea (apnea-hypopnea index > or equal to 15)

Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents

Ambulatory patient

Disqualifiers

Acute hepatic failure, biliary cirrhosis, cholestasis

Acute hypertension (SBP>= 180 mmHg and/or DBP >= 110 mmHg)

Contraindication to CPAP treatment

Trial design

Treatments tested in this trial

  • Physical activity

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

5
Canada
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Québec Canada
France
Hopital Universitaire de Grenoble38700, La Tronche France
Clinique Pasteur31300, Toulouse France
Switzerland
Hopitaux Universitaires de Genève Geneva Switzerland

Sponsors and collaborators

AGIR à Dom

Lead sponsor

University Hospital, Grenoble

Collaborator